Skip to contentA
Accendra Health Inc
A
ACHAccendra Health Inc Source filing unavailable
Q2 2016 · —
Revenue$2.48B$2.48B+2.5% vs Q2 2015 Net Income$27.72M$27.72M+14.4% vs Q2 2015 EPS Diluted$0.45$0.45+15.4% vs Q2 2015 Gross Profit$299,420,000+0.4% Operating Income$52,054,000+8.8% Operating Cash Flowderived
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Accendra Health Inc · CIK 75252 · Engraved from SEC EDGAR
-$1,909,000
N/M
Free Cash Flowderived-$5,483,000N/M Margins · derivedGross margin12.1%−0.3 pt vs Q2 2015
Operating margin2.1%+0.1 pt vs Q2 2015
Net margin1.1%+0.1 pt vs Q2 2015